NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

NEW YORK — NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Starting tonight, in solidarity with our brother and current NBA official, Scott Wall, each NBA Referee will be using a #31 ...

A benefit event will be held this weekend to raise funds for medical expenses for a four-year-old girl diagnosed with ...

Loved ones of Remi Wissinger, a Central Texas four-year-old with leukemia, are asking for the community to come support her ...

Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ...

Syndax Pharmaceuticals (SNDX) stock dropped ~23% after the company posted Phase 2 trial data for its AML candidate, revumenib ...